A new study has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient’s DNA, which is prone to developing mutations.
A new study has shown that susceptibility to a series of blood cancers, known as myeloproliferative disorders (MPDs), is linked to a particular area of the patient’s DNA, which is prone to developing mutations.